Evome Medical Technologies (Evome Medical Technologies) Cyclically Adjusted PS Ratio : 0.88 (As of May. 17, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies Cyclically Adjusted PS Ratio?

As of today (2024-05-17), Evome Medical Technologies's current share price is $0.21. Evome Medical Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $0.24. Evome Medical Technologies's Cyclically Adjusted PS Ratio for today is 0.88.

The historical rank and industry rank for Evome Medical Technologies's Cyclically Adjusted PS Ratio or its related term are showing as below:

LNDZF' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.56 Med: 0.67 Max: 0.83
Current: 0.58

During the past years, Evome Medical Technologies's highest Cyclically Adjusted PS Ratio was 0.83. The lowest was 0.56. And the median was 0.67.

LNDZF's Cyclically Adjusted PS Ratio is ranked better than
84.14% of 473 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs LNDZF: 0.58

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Evome Medical Technologies's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.147. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.24 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation

Evome Medical Technologies Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Evome Medical Technologies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies Cyclically Adjusted PS Ratio Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

Cyclically Adjusted PS Ratio

Get a 7-Day Free Trial

0.64

Evome Medical Technologies Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															-	-	-	-	0.64

Competitive Comparison of Evome Medical Technologies's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Evome Medical Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evome Medical Technologies's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Evome Medical Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Evome Medical Technologies's Cyclically Adjusted PS Ratio falls into.

Evome Medical Technologies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Evome Medical Technologies's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio	=	Share Price	/	Cyclically Adjusted Revenue per Share
	=	0.21	/	0.24
	=	0.88

Evome Medical Technologies's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Evome Medical Technologies's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare	=	Revenue per Share	/	CPI of Dec. 2023 (Change)	*	Current CPI (Dec. 2023)
	=	0.147	/	129.4194	*	129.4194
	=	0.147

Current CPI (Dec. 2023) = 129.4194.

Evome Medical Technologies Quarterly Data

	Revenue per Share	CPI	Adj_RevenuePerShare
201312	0.000	98.326	0.000
201403	0.000	99.695	0.000
201406	0.002	100.560	0.003
201409	0.002	100.428	0.003
201412	0.000	99.070	0.000
201503	0.002	99.621	0.003
201508	0.036	100.548	0.046
201511	0.021	100.135	0.027
201602	0.007	100.040	0.009
201605	0.023	101.355	0.029
201608	0.025	101.617	0.032
201611	0.026	101.829	0.033
201702	0.024	102.779	0.030
201705	0.026	103.256	0.033
201708	0.024	103.587	0.030
201711	0.023	104.072	0.029
201802	0.018	105.052	0.022
201805	0.023	106.148	0.028
201808	0.021	106.383	0.026
201811	0.020	106.338	0.024
201902	-0.034	106.649	-0.041
201905	0.007	108.048	0.008
201908	0.010	108.245	0.012
201911	0.006	108.519	0.007
202002	-0.014	109.139	-0.017
202005	0.000	108.175	0.000
202008	0.002	109.662	0.002
202011	0.007	109.793	0.008
202102	0.420	110.968	0.490
202105	0.014	113.576	0.016
202108	0.071	115.421	0.080
202111	0.094	117.269	0.104
202202	0.133	119.703	0.144
202205	0.145	123.323	0.152
202208	0.142	124.958	0.147
202211	0.142	125.607	0.146
202303	0.125	127.348	0.127
202306	0.169	128.729	0.170
202309	0.153	129.860	0.152
202312	0.147	129.419	0.147

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Evome Medical Technologies (OTCPK:LNDZF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Evome Medical Technologies Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.